| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Wafik El-Deiry | Q4118647 |
| P2093 | author name string | Wafik S El-Deiry | |
| P2860 | cites work | The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases | Q24319848 |
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| Definition of a consensus binding site for p53 | Q28207794 | ||
| p21 is a universal inhibitor of cyclin kinases | Q28257305 | ||
| Identification of p53 as a sequence-specific DNA-binding protein | Q28282745 | ||
| A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia | Q29615437 | ||
| Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control | Q29616465 | ||
| p21 in cancer: intricate networks and multiple activities | Q30436015 | ||
| WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis | Q72269510 | ||
| Hematopoietic stem cell quiescence maintained by p21cip1/waf1 | Q73532192 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5189-5191 | |
| P577 | publication date | 2016-09-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy | |
| P478 | volume | 76 |
| Q88524972 | A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis |
| Q89983578 | Basic Hallmarks of Urothelial Cancer Unleashed in Primary Uroepithelium by Interference with the Epigenetic Master Regulator ODC1 |
| Q92187472 | Cell Death Response to DNA Damage |
| Q64066914 | Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment |
| Q52729055 | Dynamic imaging of adaptive stress response pathway activation for prediction of drug induced liver injury. |
| Q47232451 | EZH2 Represses the B Cell Transcriptional Program and Regulates Antibody-Secreting Cell Metabolism and Antibody Production |
| Q64101710 | FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21 |
| Q89886166 | Finding an efficient tetramethylated hydroxydiethylene of resveratrol analogue for potential anticancer agent |
| Q92674152 | Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction |
| Q92912365 | ISG15 Deficiency Enhances HIV-1 Infection by Accumulating Misfolded p53 |
| Q55073830 | KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer. |
| Q91774056 | Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux |
| Q90169632 | Long noncoding RNA GAS5 induces abdominal aortic aneurysm formation by promoting smooth muscle apoptosis |
| Q89805913 | Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients |
| Q64061957 | MYC Oncogene Contributions to Release of Cell Cycle Brakes |
| Q60907690 | Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States |
| Q91797826 | Molecular networks of FOXP family: dual biologic functions, interplay with other molecules and clinical implications in cancer progression |
| Q91925498 | N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21 |
| Q54977379 | NSC 95397 Suppresses Proliferation and Induces Apoptosis in Colon Cancer Cells through MKP-1 and the ERK1/2 Pathway. |
| Q89637305 | Nuclear Translocation of Glutaminase GLS2 in Human Cancer Cells Associates with Proliferation Arrest and Differentiation |
| Q99710773 | PIK3R3 inhibits cell senescence through p53/p21 signaling |
| Q93140700 | Propionate of a microbiota metabolite induces cell apoptosis and cell cycle arrest in lung cancer |
| Q94554680 | Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21 |
| Q90059404 | Role of LINC00152 in non-small cell lung cancer |
| Q52579803 | Silencing of long non-coding RNA MIR22HG triggers cell survival/death signaling via oncogenes YBX1, MET, and p21 in lung cancer. |
| Q92277659 | Sirt1-inducible deacetylation of p21 promotes cardiomyocyte proliferation |
| Q92354584 | THAP7 promotes cell proliferation by regulating the G1/S phase transition via epigenetically silencing p21 in lung adenocarcinoma |
| Q92783649 | The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy |
| Q99708992 | The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing |
| Q64094918 | The cardiomyocyte "redox rheostat": Redox signalling via the AMPK-mTOR axis and regulation of gene and protein expression balancing survival and death |
| Q90421781 | The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancer |
| Q57105513 | The regulatory roles of lncRNAs in the process of breast cancer invasion and metastasis |
| Q92025479 | Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain |
| Q57469903 | USP18 (UBP43) Abrogates p21-Mediated Inhibition of HIV-1 |
| Q90108778 | Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination |
| Q100958819 | p21CIP1 controls the squamous differentiation response to replication stress |
| Q94671691 | p53: 800 million years of evolution and 40 years of discovery |
Search more.